Lifeline Biotechnologies, Inc. Prepares for Patent Application Filing
Business Wire "US Press Releases "
RENO, Nev.--(BUSINESS WIRE)--
Lifeline Biotechnologies, Inc. (Pink Sheets:LBTN) today announced the Company is preparing to file a patent application covering certain advancements it has achieved as a result of its continued research and development program concerning it First Warning System(TM) a process to assist in the early detection of breast cancer.
Jim Holmes, CEO of Lifeline, said, "We have received the preliminary draft of a patent application from the Company's corporate patent counsel. The application covers certain Neural Net Based Classification of Breast Cancer with blind thermal data screening for detecting breast cancer in women. This patent will add substantially to the intellectual property of the Company in terms of protecting its ability to use the temperatures given off by the earliest and smallest breast tumors as a means of detecting breast cancer at a stage when treatment is less invasive and less costly."
Dr. Louis Keith, Lifeline's Medical Director stated, "The new technology represents a refinement designed to minimize the likelihood of false positive results with the First Warning System(TM)."
Share Exchange, Series B Convertible Preferred for Common Shares
The cut-off date for the previously announced exchange of series B preferred stock for common stock, for shareholders to submit their common shares to Lifeline's Transfer Agent, OTC Corporate Stock Transfer, Jericho, NY, has been extended to May 18, 2007. The exchange is for one share of preferred, valued at $1.00 each for each 1600 shares of common stock submitted. The value of the common stock is $.000625 per share, a premium over the current market price. To qualify for the exchange, shareholders must submit a minimum of 100,000 common shares. The Series B Preferred Stock is valued at $1.00 per share for future conversion purposes. The Company will be sending an Information Statement disclosing the terms and conditions of the exchange. In addition, particulars concerning the exchange will be posted on Lifeline's website www.lbtn.com.
About Lifeline Biotechnologies, Inc.
Lifeline Biotechnologies, Inc. has recently reacquired the First Warning System(TM) which it had sold in 2006. The Company will focus on completing the development of the First Warning System(TM), designed to assist in the early detection of breast cancer. The underlying technology, upon which the First Warning System(TM) is based, holds the possibility of eliminating over 90% of unnecessary breast biopsies performed each year. The potential savings could reach $2.8 billion annually. Additionally, the First Warning System(TM) could conceivably eliminate the need for suggested MRIs, a savings of another $1.3 billion. Upon successful completion of the development of the First Warning System(TM), conducting clinical trials and obtaining FDA pre-marketing clearance, Lifeline will commence marketing its breast cancer early detection system. Of the approximately $138 billion spent on cancer each year, Lifeline could potentially save the healthcare industry up to $4.1 billion annually. More information is available at the Company's website: www.lbtn.com.
Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
To automatically receive instant updates, press releases, and other information on this and other Big Apple Consulting USA companies, please visit www.bigappleconsulting.com/compro.php and download your FREE copy of Big Apple ComPro.
Source: Lifeline Biotechnologies, Inc.
Posted by lostone on :
volume going fast
Posted by StockBoy10 on :
GETTING VOLUME COULD BE THE NEXT SUB RUNNER
Posted by lostone on :
This is all i can find on it... I hope they're not diluting O/S is close to A/S
LBTN -- Lifeline BioTechnologies, Inc. Com ($0.001) Search for Dun & Bradstreet reports on this company.
Address: 1325 Airmotive Way Suite 175 Reno, NV 89502 USA
Business Description: Medical Product Development with focus on assisted Breast Cancer Detection Systems; Business Development and Diversification with a focus on Alternate Energy.
Primary State of Incorporation: Nevada
Country of Incorporation: USA Year of Incorporation 1994
Officers: Jim Holmes, CEO/Treasurer; Louis Keith, Vice President/Secretary; Fred Schiemann, Controller/Asst. Secret/Asst. Treasurer
Fiscal Year End: December 31
Edgar Filing Status: Non EDGAR Filer
Sedar Filing Status: Non SEDAR Filer
Outstanding Shares: 6,650,250,000 as of 2007-01-22
Estimated Market Cap: Not Available Authorized Shares: 9,500,000,000 as of 2007-01-22 Number of Shareholders of Record: 9,500 as of 2007-01-22
Current Capital Change: Stk. Div.=15% Ex-Date: 2006-04-11 Record Date: 2006-04-14 Pay Date: 2006-05-01
Dividends: Amount: Div: 13,000,000 Solos Com shs Pay Date: 2006-09-30 Record Date: 2006-08-18
Class Notes: Div. One sh Natures Creations, Inc. Com for each sh Com held. Rec date=6-28-99. Pay date=8-24-99 Capital Change=shs decreased by 1 for 50 split. Pay date=07/08/1998. Capital Change=shs decreased by 1 for 200 split. Pay date=5-21-03 Capital Change=shs decreased by 1 for 150 split. Pay date=10/22/2004.
Transfer Agent: OTC Corporate Transfer Service Co., Hicksville, NY 11802
Posted by tompom on :
be careful next rs around the corner
Posted by barbahold on :
just bought........
Posted by Happy Valley on :
I would flip as soon as possible...I got stuck in this on the last momo run...This is the TA's phone number 516-932-2080...
Called TA back on March 28th Authorized - 9,500,000,000 Outstanding - 8,967,000,071 Restricted - 60,183,570
These are the numbers from March 19th Authorized - 9,500,000,000 Outstanding - 7,707,162,501 Restricted - 60,183,570
Posted by lostone on :
doesn't seem like a dilution.. i don't think..
Posted by StockBoy10 on :
MORE LBTN NEWS
Yahoo!My Yahoo!Mail Make Y! your home pageYahoo! SearchSearch:Welcome, none_taken11 [Sign Out, My Account]Finance Home -Help
Press Release Source: Lifeline Biotechnologies, Inc.
Lifeline Biotechnologies, Inc. to Release Initial Report on First Warning's(TM) New Algorithm Tuesday May 1, 8:31 am ET
RENO, Nev.--(BUSINESS WIRE)--Lifeline Biotechnologies, Inc. (Pink Sheets:LBTN - News) today announced that diagnostic success appears on the horizon for Lifeline's First Warning System(TM) which is designed to assist in the early detection of breast cancer. The company is expecting to soon release a promising initial report on its new algorithm developed by its study group. ADVERTISEMENT
Louis Keith, MD, PhD, Lifeline's Medical Director and Vice President, stated that on their recent visit to SE Asia, he and Jim Holmes, Lifeline's CEO, met with two eminent scientists of a prestigious technical university, engineers in the field of pattern recognition. These engineers, associated with Lifeline during the last three years, are assisting the Company in the development of new neural networks and have been working with the process to eliminate noise for the patient thermal data recorded by the First Warning System(TM). Thus far, the preliminary results have produced much better results in terms of reducing false positive and false negative interpretations.
Jim Holmes stated, "The Company's next step is to examine a larger group of women to verify what we have discovered."
Share Exchange, Series B Convertible Preferred for Common Shares
The cut-off date, for the previously announced exchange of series B preferred stock for common stock, for shareholders to submit their common shares to Lifeline's Transfer Agent, OTC Corporate Stock Transfer, Jericho, NY, has been extended to May 18, 2007. The exchange is for one share of preferred, valued at $1.00 each for each 1600 shares of common stock submitted. The value of the common stock is $.000625 per share, a premium over the current market price. To qualify for the exchange, shareholders must submit a minimum of 100,000 common shares. The Series B Preferred Stock is valued at $1.00 per share for future conversion purposes. The Company will be sending an Information Statement disclosing the terms and conditions of the exchange. In addition, particulars concerning the exchange will be posted on Lifeline's website www.lbtn.com.
About Lifeline Biotechnologies, Inc.
Lifeline Biotechnologies, Inc. has recently reacquired the First Warning System(TM) which it had sold in 2006. The Company will focus on completing the development of the First Warning System(TM), designed to assist in the early detection of breast cancer. The underlying technology, upon which the First Warning System(TM) is based, holds the possibility of eliminating over 90% of unnecessary breast biopsies performed each year providing a potential savings of up to $2.8 billion annually. Additionally, the First Warning System(TM) could conceivably eliminate the need for suggested MRIs, a savings of another $1.3 billion. Of the approximately $138 billion spent on cancer each year, Lifeline could potentially save the healthcare industry up to $4.1 billion annually. Upon successful completion of the development of the First Warning System(TM), conducting clinical trials and obtaining FDA pre-marketing clearance, Lifeline will commence marketing its breast cancer early detection system. More information is available at the Company's website: www.lbtn.com.
Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
To automatically receive instant updates, press releases, and other information on this and other Big Apple Consulting USA companies, please visit www.bigappleconsulting.com/compro.php and download your FREE copy of Big Apple ComPro.
Contact: Lifeline Biotechnologies, Inc. Rodney Marvel, Investor Relations, 1-866-THE-APPL(E) www.lbtn.com
-------------------------------------------------------------------------------- Source: Lifeline Biotechnologies, Inc.
Email Story Set News Alert Print Story
Related Quote LBTN.PK 0.00 0.00 News View Detailed Quote Delayed 20 mins Providers - Disclaimer
Related News Stories · Lifeline Biotechnologies, Inc. Prepares for Patent Application Filing - Business Wire (Mon Apr 30) · CORRECTING and REPLACING Lifeline Biotechnologies, Inc. Extends Stock Exchange Date - Business Wire (Fri Apr 27) · Lifeline Biotechnologies, Inc. Extends Stock Exchange Date - Business Wire (Thu Apr 26) · Lifeline Biotechnologies, Inc. Authorizes Stock Exchange Program to Shareholders - Business Wire (Thu Apr 5) More...
ADVERTISEMENT
Reno 911: Miami The Number 23
The Messengers Ghost Rider
The Astronaut Farmer Breach
Top Stories · Stocks Head for Moderately Higher Open - AP (8:09 am) · Procter & Gamble Earnings Rise 14 Pct. - AP (8:36 am) · Archer Daniels Midland Profit Rises - AP (8:08 am) · Sirius Satellite Radio 1Q Loss Shrinks - AP (8:03 am) More...
volume is matching yesterday's
Posted by TopRob on :
Bid and Ask is the same at .0001 that means it will be headed to .0002 soon. This will be an easy double $$.
Posted by Fuzzy1018 on :
big buys today, I'm in aswell at .0001 big news today, could be a major medical breaktrough.
Posted by TopRob on :
More good news --------------------
Lifeline Biotechnologies, Inc. Enters Negotiations for Final Phase of First Warning System(TM) Development Wednesday May 2, 8:35 am ET
RENO, Nev.--(BUSINESS WIRE)--Lifeline Biotechnologies, Inc. (Pink Sheets:LBTN - News) today announced that it has entered into final negotiations for the final development of the computer software system, the related technology is the basis for its First Warning System(TM). The First Warning System(TM) is designed to assist in the early detection of breast cancer.
Jim Holmes, Lifeline's CEO stated, "We are in the final stages of negotiation with a major southeast Asian based university to complete development of the software technology which provides the capability of the Company's First Warning System(TM) to assist in the early detection of breast cancer. Lifeline has been working with engineers at the university for several years on an informal basis and a contract for a formal arrangement will be concluded. The software development is expected to be completed near term. Upon completion of the development involving the analysis of approximately 100 to 150 patient data from women previously tested using Lifeline's First Warning System(TM), additional clinical testing will be undertaken in order to validate this cutting edge technology. To date, the development has indicated a potential breakthrough in identifying breast cancer and the false positives and false negatives have been within acceptable levels."
Share Exchange, Series B Convertible Preferred for Common Shares
The cut-off date, for the previously announced exchange of series B preferred stock for common stock, for shareholders to submit their common shares to Lifeline's Transfer Agent, OTC Corporate Stock Transfer, Jericho, NY, has been extended to May 18, 2007. The exchange is for one share of preferred, valued at $1.00 each for each 1600 shares of common stock submitted. The value of the common stock is $.000625 per share, a premium over the current market price. To qualify for the exchange, shareholders must submit a minimum of 100,000 common shares. The Series B Preferred Stock is valued at $1.00 per share for future conversion purposes. The Company will be sending an Information Statement disclosing the terms and conditions of the exchange. In addition, particulars concerning the exchange will be posted on Lifeline's website www.lbtn.com.
About Lifeline Biotechnologies, Inc.
Lifeline Biotechnologies, Inc. has recently reacquired the First Warning System(TM) which it had sold in 2006. The Company will focus on completing the development of the First Warning System(TM), designed to assist in the early detection of breast cancer. The underlying technology, upon which the First Warning System(TM) is based, holds the possibility of eliminating over 90% of unnecessary breast biopsies performed each year providing a potential savings of up to $2.8 billion annually. Additionally, the First Warning System(TM) could conceivably eliminate the need for suggested MRIs, a savings of another $1.3 billion. Of the approximately $138 billion spent on cancer each year, Lifeline could potentially save the healthcare industry up to $4.1 billion annually. Upon successful completion of the development of the First Warning System(TM), conducting clinical trials and obtaining FDA pre-marketing clearance, Lifeline will commence marketing its breast cancer early detection system More information is available at the Company's website: www.lbtn.com. Posted by Fuzzy1018 on :
yea, another good news. medical breakthrough on horizon, I really need a big percentage gainer maybe this one is it.
Posted by barbahold on :
bought today for .0001...
Posted by MichaelAdamGreen on :
barbara... where in NC are you from - Charlotte HERE... anywho - This used to go up and down from 1 to 2 all day long and has been dead for a long time. I am holding a few million shares and hope all of this is true!
Posted by TopRob on :
I passed up WTVI.PK to buy into this one, well I hope it comes through because WTVI just doubled today. I think I'm gonna be sick.
Posted by barbahold on :
I dont understand why anyone would sell at .0001.Especially with the news that came out........
Posted by TopRob on :
They must be diluting. It will never go up as long as they keep supplying new shares at .0001
Posted by barbahold on :
I know I sound ignorant.I am about stocks,but will never know withou asking.Exactly what does that mean?.thanks
Posted by T e x on :
compay releasing shares into the market, one way or another: adds to OS, thus "diluting" pps...
Posted by barbahold on :
thank you.........
Posted by TopRob on :
Diluting hurts in several ways 1) It causes the pps to drop quickly. In this case it just stays at bottom. 2) It eliminates buyers that would have paid a higher price. Everyone now get it cheap, so that leaves no new buyers to bring the price up again. 3) This scares away new investors that would have bought in. 4) It's an indication that the company is in financial trouble. 5) It means the company leaders just don't know what they are doing.
The sad thing is that all companies do this even the major players. The difference is that the betters companies do it in small chunk when things are looking good, so it goes unnoticed. The struggling companies do it because they either need the cash to fund and finish their project or they are in financial trouble and need the cash to prevent from going under. Worst case is that they are a scam from the start and they only make money by issuing shares and R/S and repeating the process.
I think LBTN is using it to fund their research, so that a good thing unless it goes on too long.
Posted by barbahold on :
activity
Posted by TopRob on :
Huge volume 419M. Something's up. I just wish it would move up.
Posted by megahead34 on :
Yep. i think you're right about dilluting. Just about all of these small companies do this junk. They need money to pay of all other things.
Posted by Fuzzy1018 on :
someone bought 40mil earlier at .0008 WOW, something major comin' our way imo
Posted by PCola77 on :
huh?
quote:Originally posted by Fuzzy1018: someone bought 40mil earlier at .0008 WOW, something major comin' our way imo
Posted by TopRob on :
They called back the .0008 so it never happened, but it finally went to .0002 and now the Ask has moved to .0002
Posted by TopRob on :
Wow! Volume over 1.2Bil today. They must be making good progress on the breast cancer detection software. Huge trades today some over 100Mil probably major investors getting in. Somebody knows something, so next week is going to be exciting as it moves above .0001.
Posted by lostone on :
quote:Originally posted by TopRob: Wow! Volume over 1.2Bil today. They must be making good progress on the breast cancer detection software. Huge trades today some over 100Mil probably major investors getting in. Somebody knows something, so next week is going to be exciting as it moves above .0001.
either that or dilution, anyone know the O/S?
Posted by Gary59 on :
This is the last info from Pinksheets..:
Outstanding Shares: 6,650,250,000 as of 2007-01-22
Estimated Market Cap: Not Available Authorized Shares: 9,500,000,000 as of 2007-01-22 Number of Shareholders of Record: 9,500 as of 2007-01-22
Current Capital Change: Stk. Div.=15% Ex-Date: 2006-04-11 Record Date: 2006-04-14 Pay Date: 2006-05-01
Dividends: Amount: Div: 13,000,000 Solos Com shs Pay Date: 2006-09-30 Record Date: 2006-08-18
Class Notes: Div. One sh Natures Creations, Inc. Com for each sh Com held. Rec date=6-28-99. Pay date=8-24-99 Capital Change=shs decreased by 1 for 50 split. Pay date=07/08/1998. Capital Change=shs decreased by 1 for 200 split. Pay date=5-21-03 Capital Change=shs decreased by 1 for 150 split. Pay date=10/22/2004.
Transfer Agent: OTC Corporate Transfer Service Co., Hicksville, NY 11802
Posted by Gary59 on :
I bought $50 worth last month just for the heck of it ,, lot of volume every day but no movement and no one on bid for a while , I think there where a few MMs on bid a few days back but they are in and out... Might round out to 1 mil shares just in case it does run in the future , you never know when some of these will come off .0001.. And $100 investment, might just have fun with it ..
Posted by Ripler on :
R/S?
Posted by Fuzzy1018 on :
this one might go; .0001's building .0001/.0002
Posted by Fuzzy1018 on :
some buys at .0002
Posted by brackep on :
Lifeline Biotechnologies, Inc. Sets Record Date for Exchange of Preferred Stock for Common Stock Tuesday May 8, 10:25 am ET
RENO, Nev.--(BUSINESS WIRE)--Lifeline Biotechnologies, Inc. (Pink Sheets:LBTN - News) today announced that it has set the Record Date for its Exchange Program, Preferred Stock for Common Shares as May 21, 2007. To take advantage of the Exchange, shareholders must submit their common shares to Lifeline's Transfer Agent, OTC Corporate Stock Transfer, Jericho, NY, by May 31, 2007. The exchange is for one share of preferred, valued at $1.00 each for each 1600 shares of common stock submitted. The value of the common stock is $.000625 per share, a premium over the current market price. To qualify for the exchange, shareholders must submit a minimum of 100,000 common shares. The Series B Preferred Stock is valued at $1.00 per share for future conversion purposes. The Company will be sending an Information Statement disclosing the terms and conditions of the exchange. In addition, particulars concerning the exchange will be posted on Lifeline's website www.lbtn.com. ADVERTISEMENT
About Lifeline Biotechnologies, Inc.
Lifeline Biotechnologies, Inc. has recently reacquired the First Warning System(TM) which it had sold in 2006. The Company will focus on completing the development of the First Warning System(TM), designed to assist in the early detection of breast cancer. The underlying technology, upon which the First Warning System(TM) is based, holds the possibility of eliminating over 90% of unnecessary breast biopsies performed each year providing a potential savings of up to $2.8 billion annually. Additionally, the First Warning System(TM) could conceivably eliminate the need for suggested MRIs, a savings of another $1.3 billion. Of the approximately $138 billion spent on cancer each year, Lifeline could potentially save the healthcare industry up to $4.1 billion annually. Upon successful completion of the development of the First Warning System(TM), conducting clinical trials and obtaining FDA pre-marketing clearance, Lifeline will commence marketing its breast cancer early detection system. More information is available at the Company's website: www.lbtn.com.
Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
To automatically receive instant updates, press releases, and other information on this and other Big Apple Consulting USA companies, please visit www.bigappleconsulting.com/compro.php and download your FREE copy of Big Apple ComPro.
Contact: Lifeline Biotechnologies, Inc. Rodney Marvel, Investor Relations 1-866-THE-APPL(E) www.lbtn.com
-------------------------------------------------------------------------------- Source: Lifeline Biotechnologies, Inc.
Posted by TopRob on :
This could be a good deal. It's like selling your shares at .000625 for a huge 625% profit (assuming you bought them at .0001). This also reduces the O/S without doing a R/S. The only drawback is that they will probably have a long mature date.
Posted by MichaelAdamGreen on :
Ok - HOW DO WE SELL FOR .000625?
They can have my 2 million shares for $1,000... I'll cut them a deal!
Posted by MichaelAdamGreen on :
...OR - do they think this stock is going to go up significantly. Why would they buy stocks back for 6 times what it is going for?
Posted by TopRob on :
quote:Originally posted by MichaelAdamGreen: ...OR - do they think this stock is going to go up significantly. Why would they buy stocks back for 6 times what it is going for?
I think the main reason for this offer is to reduce the outstanding shares without doing a R/S. The Outstanding Shares as of Jan 22 is 6,650,250,000 which is why the pps is now at .0001. So let's say that if enough shareholders signed up to equal half that, then that would drop the O/S down to 3,325,125,000 for trading. You would not be able to sell your pererred shares right away, so that would basically increase the share value.
Posted by TopRob on :
Next Thrusday (May 31) is the dedline to trade in for the preferred shares. If enough people convert their shares that will reduce the O/S and maybe the pps will rise again starting June 1st.
Posted by brackep on :
let's hope so
Posted by MichaelAdamGreen on :
Who all is converting? How much did your broker charge to convert? I'm switching half and they charged $40 per million.
Posted by TopRob on :
Lifeline Biotechnologies, Inc. Finalizes Preferred Stock Exchange Guidelines Friday May 25, 12:05 pm ET
RENO, Nev.--(BUSINESS WIRE)--Lifeline Biotechnologies, Inc. (OTCPK:LBTN) today announced that it has finalized the details for the Preferred Stock Exchange. An Information Statement has been mailed to each of Lifeline Biotechnologies, Inc.'s shareholders of record as of May 21, 2007. The Information Statement has been posted to Lifeline's website: www.lbtn.com. Below are the key elements of the Information Statement-Exchange Convertible Preferred Stock Series B (Preferred Stock):
Record Date to participate in the exchange was: May 21, 2007. Delivery date to the transfer agent of Common Stock Certificates: June 15, 2007. Exchange Ratio: One Share of Preferred Stock for each 1,600 common shares submitted to Lifeline Transfer Agent by June 15, 2007. To be eligible for the exchange a minimum of 25,000 shares of common stock is required to be submitted. The Preferred Stock is convertible to common stock after December 31, 2008 at a rate of $0.10 per share or the market price, whichever is greater. The Preferred Stock does not and is not expected to have a public trading market. The Preferred Stock is callable by the Company after March 31, 2009 at $.01 per share. Lifeline's Board of Directors has approved a One for Sixteen Hundred (1/1,600) reverse split, of post exchange common shares, expected to become effective before July 15, 2007.
About Lifeline Biotechnologies, Inc.
Lifeline Biotechnologies, Inc. has recently reacquired the First Warning System(TM) which it had sold in 2006. The Company will focus on completing the development of the First Warning System(TM), designed to assist in the early detection of breast cancer. The underlying technology, upon which the First Warning System(TM) is based, holds the possibility of eliminating over 90% of unnecessary breast biopsies performed each year providing a potential savings of up to $2.8 billion annually. Additionally, the First Warning System(TM) could conceivably eliminate the need for suggested MRIs, a savings of another $1.3 billion. Of the approximately $138 billion spent on cancer each year, Lifeline could potentially save the healthcare industry up to $4.1 billion annually. Upon successful completion of the development of the First Warning System(TM), conducting clinical trials and obtaining FDA pre-marketing clearance, Lifeline will commence marketing its breast cancer early detection system More information is available at the Company's website: www.lbtn.com. Posted by TopRob on :
This is just outrageous. First (in the May 8 PR)they said each converted share would be worth $1.00, now they are saying .10. Before 1M shares would have been worth $625, but now it would only be worth $62.50 one year later. What a rip off.
Just how can they get away with this type of deception.
Posted by madmoney on :
Posted by MichaelAdamGreen on :
i agree TopRob... Isn't it funny how that came out 4 days after they initially said that everyone could exchange their shares. Everyone, like ourselves prob. RUSHED to take advantage of this "deal" and then once they had enough people committed, they would drop us. That seems like fraud/scam in more ways than 1. I feel like this is just going to plummet once the change is effective. This really chaps my ass.
Posted by triovestor on :
yep
Posted by triovestor on :
My instincts told me to buy couple mil of this .
Don't run to convert and to sit and wait .
I feel fine on this still { my investment is only 200 bucks }
Posted by brackep on :
What if enough shares are converted thus reducing the outstanding shares so that the r/s will be canceled ? That would be some big news IMO ...
Posted by triovestor on :
That would be very good .
Infact that would have a powerful effect on producing higher share price .
Posted by brackep on :
quote:Originally posted by triovestor: That would be very good .
Infact that would have a powerful effect on producing higher share price .
well there is a chance this might actually be true, I've seen this rumor on other boards however it stays a rumor until pr'ed ...
would be great if it were to be true!
Posted by brackep on :
something that could point out there's something in the works like for example a R/S cancel (IMO):
"Lifeline's Board of Directors has approved a One for Sixteen Hundred (1/1,600) reverse split, of post exchange common shares, expected to become effective before July 15, 2007"
Why wait till July 15th if the board has approved it already ?
Posted by TopRob on :
Converting to Preferred and R/S is almost the same thing now. Either way you end up with the same number of shares, 625 per million. However, no one is going to convert now because that would actually be worst than the R/S. With the convert you automatically loose 37.5% plus you will have to wait a year to cash in. With the R/S you loose 37.5% of shares, but the pps calculates to .16 and since everyone loose the same amount, you could get more than the preferred if the pps stays above .10 (the preferred converted value). Sounds confusing.
Before R/S 1,000,000 shares = $100 at .0001
After R/S 625 shares = $100 at .16, you loose nothing if pps stays level
After R/S 625 shares = $62.50 at .10, you loose 37.5% if pps drops to this
Preferred 625 shares = $62 at any pps value, you loose 37.5% instantly no matter what
We are just screwed on this one. The crooks running this company should go to jail on this trick of deception.
Posted by brackep on :
I contacted Mr. Holmes because of the next lines in their PR:
"Lifeline's Board of Directors has approved a One for Sixteen Hundred (1/1,600) reverse split, of post exchange common shares, expected to become effective before July 15, 2007"
I asked myself why wait till July 15th if the board has approved the R/S already ?
I asked Mr. Holmes if they were considering to cancel the R/S ...
his answer (between ************):
************************************************************* If enough shareholders were to convert to preferred shs.... we could consider foregoing the reverse.
We'll take a look after the common stock certificate submission date for the exchange, June 15, 2007.
Appreciate your observation. Regards, Jim Holmes *************************************************************
Posted by TopRob on :
Brackep, it's no point in getting your hopes up on this one. I see SCAM in big letters on this one.
They have 6.6B O/S as of Jan 07, probably 7B by now. They knew the pps was going to be driven down by diluting, but they just kept on doing it until it hit .0001. Now they want to R/S to bring the pps up to .16, but they will still be a penny stock, so nothing great about that. So the real reason is they can't dilute anymore since no more buyers at .0001, so after R/S they will be able to start diluting billions of shares again. Why dilute? Well, that seem to be their only revenue now days. Diluting 1 billion shares at .01 average is $10M. Now if they had a good product, people would buy in and the pps would go up, but now it's diluted too much. Without a plan to increase revenue and reduce the O/S, this is just a POS.
Outstanding Shares: 6,650,250,000 as of 2007-01-22
Estimated Market Cap: Not Available Authorized Shares: 9,500,000,000 as of 2007-01-22 Number of Shareholders of Record: 9,500 as of 2007-01-22
Posted by TopRob on :
I wish they make up their mines on the convertable shares price. First $1.00 then .10 now $1.00 again for each 1,600 shares. They also extended the deadline. No mention of the R/S. -----------------------------------------
Lifeline Biotechnologies, Inc. Nears Finalization of Terms For Its First Warning System(TM) Development Friday June 8, 9:40 am ET
RENO, Nev.--(BUSINESS WIRE)--Lifeline Biotechnologies, Inc. (Pink Sheets:LBTN - News) today reported that it is nearing final negotiations for what is expected to be the final development of the computer software system and the related technology which is the basis for its First Warning System(TM). The First Warning System(TM) is designed to assist in the early identification of breast cancer.
Jim Holmes, Lifeline's CEO, stated "Though it has taken longer than hoped, progress leading to a final agreement and terms, for what is expected to be, the last phase of the technical development for our First Warning System's interpretative capabilities is nearing a favorable conclusion. Once the agreement is in place expectations are the development should move ahead quickly. Once completed, the system is designed to identify breast cancer at a very early stage. With the interpretative capabilities completed, further clinical trials and FDA marketing clearance will be required in order to commence a commercial rollout of the product."
Share Exchange, Series B Convertible Preferred for Common Shares
The cut-off date, for the previously announced exchange of series B preferred stock for common stock, for shareholders to submit their common shares to Lifeline's Transfer Agent, OTC Corporate Stock Transfer, Jericho, NY, has been extended to June 15, 2007. The exchange is for one share of preferred, valued at $1.00 each for each 1600 shares of common stock submitted. The value of the common stock is $.000625 per share, a premium over the current market price. To qualify for the exchange, shareholders must submit a minimum of 25,000 common shares and are of record May 21, 2007 . The Series B Preferred Stock is valued at $1.00 per share for future conversion purposes. The Company has sent an Information Statement disclosing the terms and conditions of the exchange. In addition, particulars concerning the exchange have been posted on Lifeline's website www.lbtn.com. Posted by MichaelAdamGreen on :
Yeah - that's good and well until they change it again right before it switches... We'll see.
Posted by TopRob on :
If it's really going to be $1.00, I'll comvert because that would be better than going through the R/S that they mignt do.
Do the math: 1M Converted: Becomes 625 shares and be worth $625. 1M R/S: Now worth $100, becomes 625 shares, would most likely drop 50% and be worth $50.
Posted by Gary59 on :
Here's an email I just recieved from scottrade.. I bought 50 bucks worth a few month back as a gamble so I have 500000 shares ..
Re. stock symbol LBTN :
The above-listed stock is part of a non-mandatory reorganization or tender offer, which requires your timely attention. For details regarding this offer, contact your local branch office. Please note that failure to advise Scottrade of your intent may result in no action being taken, and we cannot be held responsible for any resulting loss.
If you decide to participate in this offer, you will need to inform your local Scottrade branch office no later than 9 a.m. CST on the expiration date, and a $25 fee will be charged to your account.
These shares must then remain in your account until the reorg/tender takes place (be advised that the expiration date for such actions is often extended). Please contact us if you have any questions.
Eric Swenson Scottrade, Inc. 505 Beachland Blvd, Ste 8 Vero Beach, FL 32963 Phone: 772-234-1998 Toll Free: 877-878-2023 Fax: 772-234-1948
Posted by Gary59 on :
Gues sI will call Monday it will cost me another 25 to convert and if it works out as they say ( never happens) then 75 would turn into 312.00..
Posted by beechwood on :
Maybe this, what if that, if only they don't blah, blah, blah, blah, blah, blah, blah..... Wishfull thinking and a dollar will get you a cup 'o Joe at Starbucks and that's about it. As with most conversions (and I see no reason to differ here)it's just a revenue machine for no market. And when that runs it's course it's the infamous R/S for the bagholders on board. Leave this POS where it belongs -- in the round file.
Posted by TopRob on :
quote:Originally posted by beechwood: Maybe this, what if that, if only they don't blah, blah, blah, blah, blah, blah, blah..... Wishfull thinking and a dollar will get you a cup 'o Joe at Starbucks and that's about it. As with most conversions (and I see no reason to differ here)it's just a revenue machine for no market. And when that runs it's course it's the infamous R/S for the bagholders on board. Leave this POS where it belongs -- in the round file.
But if you are already in, you have no choice but to either go with the conversion for a 600% gain or wait for the R/S and sell at a great loss.
Posted by SkullsAndBones on :
I smell Scam
Posted by atleast on :
oops, big pump in effect - good chance to be out.
Watch List for Monday - 6-11-2007
hot otc dot com
**********************************
My new big pick is LBTN.
What if you could get into a medical company with a technology that could save hundreds of millions of lives and change the world as we know it? I think LBTN could be this company!!! Bio companies have been hot lately with many doubling and tripling in just days!
LBTN is probably the lowest priced company I have ever come across in my entire life. LBTN could make huge swings up and down so use caution if you attempt to trade it. It should only be attempted by savvy individuals who are looking for huge potential profit.
LBTN is currently trading low because no one knows about it yet. LBTN is in the final development stages for the computer software that will be used to detect early signs of female cancer. Currently diagnosis is made through human interpretation which can result in error but with software, detection can be made at an earlier stage.
If LBTN get FDA approval , the company could be shot into the stratosphere. Start your research on LBTN right now at: http://www.lbti.com
I will send more information on LBTN later.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. ********************************************************* The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: The ******.com employees are not Registered as an Investment Advisor in any jurisdiction whatsoever. Full disclaimer can be read at http://www.******.com/disclaimer.htm
Release of Liability: Through use of this website viewing or using you agree to hold ******.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. ******.com has been compensated by a third party Allk Inc. fifteen thousand dollars for a one month LBTN advertising contract. ******.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and ******.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. ******.com, nor any of its affiliates are not registered investment advisors or a broker dealers.
Posted by brackep on :
LBTN massive volume ...
Posted by Gary59 on :
Massive volume BUT not one is on BID the same as its been for weeks now .. I still cant see why shares are bought if no one on bid and cant sell.. I called scottrade this morning and they are goint to convert my shares IF LBTN does it and it will cost me anoth 25 but , IF it is as they say it will be worth a little over 300 buck verses zip..
Posted by TopRob on :
Wow! Started out today with a 100M trade. Now that's some serious buying. Maybe the $1.00 per 1,600 conversion is correct this time. Is so, that 100M cost $10,000 and after conversion would be worth $62,500.
Posted by TopRob on :
High Volume today = 642M
Somebody's buying in to this POS. Maybe there's a little hope left.
Posted by jadeboer on :
I need some good advise for lbtn I have called them and ameritrade and I am confussed I bought 11,430,000 shares and I don't know if I should convert or not have to deside in the next 2 hours. Please anyone help!!!!
Posted by TopRob on :
Choose to convert if you don't mind waiting until Dec 2009 to cash in. You will make 600% profit at that time if the company is doing ok. This is assuming that the convert rate is 1:1,600 at $1.00/share.
Choose to hold if you can't wait that long and hope that they don't do a R/S.
Posted by MichaelAdamGreen on :
...wait... why do you have to wait until 12/09 to sell the stocks?
Posted by madmoney on :
quote:Originally posted by MichaelAdamGreen: ...wait... why do you have to wait until 12/09 to sell the stocks?
converted shares will be restricted? until 12/09, meaning untradable until then.
Posted by TopRob on :
Lifeline Biotechnologies, Inc. Extends Delivery Date for the Exchange of Common Stock for Preferred Stock Thursday June 14, 8:00 am ET
RENO, Nev.--(BUSINESS WIRE)--Lifeline Biotechnologies, Inc. (Pink Sheets:LBTN - News) today announced that it has extended the delivery date for common shareholders to submit their shares in order to exchange their common shares for preferred shares. The extended date is June 22, 2007. Jim Holmes, Lifeline's CEO, stated, "Common shareholders as of May 21, 2007 can choose to exchange their common shares for convertible Series B Preferred Shares. We have extended the delivery date to June 22, 2007 due to the time it has taken to finalize procedures for the exchange, primarily with Depository Trust Corporation (DTC)."
Share Exchange, Series B Convertible Preferred (Preferred Stock) for Common Shares
Eligible for the Exchange: Shareholders of record as of May 21, 2007; a minimum of 25,000 common shares is required; the exchange will be one share of preferred stock for each 1,600 shares of common stock. The minimum exchange is 25,000 shares of common which will receive 15.625 (fractional shares will be rounded up) shares of preferred stock. Common shareholders electing to participate in the exchange should submit their certificates to Lifeline's Transfer Agent by the close of business June 22, 2007. Lifeline's transfer agent is:
OTC Corporate Transfer Service 52 Maple Run Dr. Jericho, NY 11753
Concerning shares held in brokerage accounts, shareholders can advise their brokers concerning their intent to participate in the exchange. The brokers provide instructions to OTC Corporate Transfer Service.
Additional terms and conditions of the convertible Series B Preferred Stock can be obtained on Lifeline's website at www.lbtn.com...... See Information Statement thereon.
Posted by TopRob on :
They explain how the conversion works on their website. The conversion is $1.00 per 1,600 common shares. The .10 (10 cents) is the minimum conversion rate. That means you will get $1.00 (no more, no less) for each converted share as long as the pps is trading at .10 (10 cents) and higher. If the pps is trading less than .10 you will get less than $1.00 per share.
So if you had 1M common that would convert to 625 Preferred. You can't cash in until after Dec 31, 2008. If the pps at that time is .10 or greater you will get $625.00. If the pps is less than .10 it converts as: PreferredShares/.10 * CurrentPPS. So if the pps is .05, you will get $312.50. If the pps is .005 you would get $31.25. If the pps is .0001 you get $0.625 ----------------------------------- From their Website:
What are the terms and conditions of the conversion rights of the Series B Convertible Preferred Stock?
No conversion of Preferred Stock to Common Stock can occur until after December 31, 2008. Thereafter, at your option, you may convert the Preferred Stock into Common Stock. For purposes of conversion, the value of each share of Preferred Stock will be deemed to be $1.00. The number of shares of Common Stock to be received upon a conversion will be based on the value of the Common Stock at the time of conversion. That value will be based on the greater of the average closing bid price of the Common Stock for each of the ten (10) consecutive trading days immediately prior to the date of conversion or TEN CENTS ($.10) per share.
Illustrations of conversion rights:
(a) The conversion rate is the greater of market or $.10 per common share. Assume you hold 1,000 shares of the Preferred Stock. Assume further that the market bid of the Common Stock is $.50 per share. The number of shares of Common Stock which you can receive upon conversion will be 2,000 ($1,000 divided by $.50 per share);
(b) Assume you hold the same 1,000 shares of the Preferred Stock. Assume further that the market bid of the Common Stock is $0.05 per share. The number of shares of Common Stock which you can receive upon conversion will be 10,000 ($1,000 divided by minimum price of $0.10 per share). The $.05 bid is below the set minimum of $.10 per share. Posted by PCola77 on :
In other words, if the PPS is .0001, you will still only get 10,000 shares, right?
I'd bank on it being a lot closer to .0001 than .50 by then.
Let me put it to you in simple terms. Would you EVER intentionally hold a pinksheet stock for 18 months, and assume the PPS will be higher than it is now?
If so, I think you're better off just writing me a check for $100, and in 18 months I'll give you back $10. I bet you anything my deal is better than this one will turn out. I won't even charge any "re-org" fees at the end.
Posted by TopRob on :
Yeah, we are screwed on this one, it's a no win situation.
1) Hold and take the R/S. Expect to loose 50% or more.
2) Convert and hope the pps is above .016 (break even point) after Dec 2008.
Posted by TopRob on :
There may be hope after all. Good news. -----------------------------------
Lifeline Biotechnologies, Inc. Finalizes Agreement For Development of Its First Warning System(TM) Monday July 9, 10:25 am ET
RENO, Nev.--(BUSINESS WIRE)--Lifeline Biotechnologies, Inc. (Pink Sheets:LBTN - News) today announced that it has finalized and executed the Agreement for the, what is anticipated to be, final stage development of its interpretive system, a system designed to assist in the early detection of breast cancer.
Jim Holmes, Lifeline's CEO, stated "the terms of the Agreement have been finalized and I have executed and sent it to the University in Singapore. I await the return executed Agreement. We have worked with the engineers at the University for over two years in the preliminary analysis of the patient data which we obtained from our patient testing in Argentina. The initial results from this preliminary patient analysis, indicates that the system holds capabilities of identifying breast cancer at a very early stage and at acceptable false positive and false negative levels. Now that the Agreement terms are final we will send the additional Argentina patient data for the engineers to analyze and the final development of our First Warning(TM) interpretive system."
Posted by TopRob on :
This could really be huge when their system is complete. LBTN pps could shoot to the moon overnight when finished. However, I wonder how just long is this final stage going to take and will they dilute to get the funds. As long as they don't do a R/S, it's a good risk that could paytout big $$.
Posted by TopRob on :
For those that didn't convert, let's hope they don't R/S ------------------------------------
Lifeline Biotechnologies, Inc. Completes Exchange of Preferred Shares for Common Shares Wednesday July 11, 10:23 am ET
RENO, Nev.--(BUSINESS WIRE)--Lifeline Biotechnologies, Inc. (Pink Sheets:LBTN - News) announced today that the exchange of Preferred Shares for Common Shares has been completed.
Jim Holmes, CEO of Lifeline Biotechnologies, stated, "The exchange of Preferred Shares for Common shares has been completed as a part of the capital restructuring of the Company. We anticipate that the exchange could provide the participating shareholders an opportunity to benefit from the impending reverse split of the remaining common shares, which is being considered by the Board of Directors."
Posted by TopRob on :
Lifeline Biotechnologies, Inc. Announces Capital Restructuring for Continued Growth and Potential Acquisitions Wednesday July 18, 8:31 am ET
RENO, Nev.--(BUSINESS WIRE)--Lifeline Biotechnologies, Inc. (Pink Sheets:LBTN - News) announced today it will be undertaking a capital restructuring to better position the Company for growth and expansion. Effective July 31, 2007, Lifeline Biotechnologies will be implementing a 1 for 1,600 reverse stock split of its outstanding common stock, subject to completion of regulatory compliance requirements.
The Lifeline Biotechnologies Board of Directors approved this capital restructure as a means to position the Company to attract possible acquisition candidates, to reduce the market volatility that Lifeline Biotechnologies shares have experienced, and to better represent the Company's current position in the medical equipment market.
Lifeline Biotechnologies, Inc. recently announced that it has finalized and executed the Agreement for the, what is anticipated to be, final stage development of its interpretive First Warning System, a system designed to assist in the early detection of breast cancer.
Posted by TopRob on :
Today is the day of the R/S. Each 1 million shares will reduce to 625. After R/S pps will become .16 and probably drop real fast.
Before R/S pps=.0001, After R/S pps=.16
Posted by BooDog on :
dilution city eh? wait for the bounce imo. gonna take one hell of a pr campaign to even have a chance - again imo. final stage... okidoki. i've been watching a few of these r/s's lately. better to wait and see what happens with a pink - imo.
Posted by TopRob on :
This POS is now trading at .021 a huge drop from the post R/S price of .16 TDA and maybe other brokers has now updated the symbol to LLBT so it looks like everyone is dumping in a hurry before the pps really tumble.